Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 22 2014
Print

Actavis Appoints Chief Accounting Officer



Published August 16, 2013
Related Searches: Development
James D'Arecca has been appointed chief accounting officer at Actavis, Inc. He reports to R. Todd Joyce, global chief financial officer. Mr. D'Arecca joins the company from Bausch & Lomb, where he served in a similar role to his new position at Actavis.
 
Prior to Bausch & Lomb, he served as executive director and business development controller at Merck, where he was the primary liaison between the controller's organization and the business development and corporate licensing functions. Previously, Mr. D'Arecca was executive director and assistant controller at Schering-Plough. He also spent 13 years with PricewaterhouseCoopers, with a focus on pharmaceuticals, medical devices and consumer products.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On